Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Dose Escalation, Safety, and Pharmacokinetic Study of CFI-402257 Administered Orally to Patients With Advanced Solid Tumors

NCT02792465 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02792465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02792465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Dose Escalation, Safety, and Pharmacokinetic Study of CFI-402257 Administered Orally to Patients With Advanced Solid Tumors
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Completed
Start date
November 11, 2016
Completion date
June 12, 2025
Enrollment
52 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid cancers, breast cancer